Estimated glomerular filtration rate in patients with surgically acquired single kidney compared with patients with congenital single kidney: Implications for kidney transplant from live donors

Experimental and Clinical Transplantation

Volumn 8, Issue 3, 2010, Pages 228-236

  Gadalean, Florica Nicoleta ^a   Gluhovschi, Gheorghe ^a   Trandafirescu, Virginia ^a   Petrica, Ligia ^a   Velciov, Silvia ^a   Bozdog, Gheorghe ^a   Gluhovschi, Cristina ^a   Bob, Flaviu ^a   Vernic, Corina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

One kidney; Renal function; Risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADOLESCENT; ADULT; AGE; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NEPHRECTOMY; OUTCOME ASSESSMENT; PROTEINURIA; RISK FACTOR; SOLITARY KIDNEY;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77957166860     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; Arbor Research Collaborative for Health, Ann Arbor, MI.
2. Klahr S, Purkerson M, Harris K. Mechanisms of progressive renal failure in experimental animals and their applicability to man. In: Brenner BM, Stein JS, eds. Contemporary Issues in Nephrology. Vol 14. New York, NY: Churchill Livingstone; 1986:1182-1191.
3. Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest. 1982; 46(3):275-281.
4. Newbold KM, Howie AJ, Girling AJ, Kizaki T, Bryan RL, Carey MP. A simple method for assessment of glomerular size and its use in the study of kidneys in acromegaly and compensatory renal enlargement. J Pathol. 1989;158(2):139-146.
5. Argueso LR, Ritchey ML, Boyle ET Jr, Milliner DS, Bergstralh EJ, Kramer SA. Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol. 1992;6(5):412-416.
6. Wikstad I, Celsi G, Larsson L, Herin P, Aperia A. Kidney function in adults born with unilateral renal agenesis or nephrectomized in childhood. Pediatr Nephrol. 1988;2(2):177-182.
7. Bhathena DB, Julian BA, McMorrow RG, Baehler RW. Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans. Am J Kidney Dis. 1985;5(5):226-232.
8. Wilson BE, Davies P, Shah K, Wong W, Taylor CM. Renal length and inulin clearance in the radiologically normal single kidney. Pediatr Nephrol. 2003;18(11):1147-1151.
9. Maluf NS. On the enlargement of the normal congenitally solitary kidney. Br J Urol. 1997;79(6):836-841.
10. Hegde S, Coulthard MG. Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney? Pediatr Nephrol. 2009;24(3):439-446.
11. Woolf AS. Perspectives on human perinatal renal tract disease. Semin Fetal Neonatal Med. 2008;13(3):196-201.
12. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int. 2006;70(10):1694-1705.
13. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-2100.
14. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev. 2002;7(1):29-49.
15. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009;31(1):47-58.
16. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992;146(11):1997-2005.
17. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens. 2001;19(9):1523-1532.
18. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008;34(1-3):36-51.
19. Seeman T, Patzer L, John U, et al. Blood pressure, renal function, and proteinuria in children with unilateral renal agenesis. Kidney Blood Press Res. 2006;29(4):210-215.
20. de Lucas C, Nocea A, San RJ, Espínola B, Ecija JL, Vázquez Martul M. Solitary kidney. Study of renal morphology and function in 95 children [in Spanish]. Nefrologia. 2006;26(1):56-63.
21. Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H. Kidney function after nephrectomy for renal cell carcinoma. Urology. 2004;64(1):43-47; discussion 48.
22. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48(3):814-819.
23. Saran R, Marshall SM, Madsen R, Keavey P, Tapson JS. Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant. 1997;12(8):1615-1621.
24. Simon J, Zamora I, Mendizabal S, Castel V, Lurbe A. Glomerulotubular balance and functional compensation in nephrectomized children. Nephron. 1982;31(3):203-208.
25. Fehrman-Ekholm I, Dunér F, Brink B, Tydén G, Elinder CG. No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up. Transplantation. 2001;72(3):444-449.
26. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med. 2009;360(5):459-469.
27. Smith S, Laprad P, Grantham J. Long-term effect of uninephrectomy on serum creatinine concentration and arterial blood pressure. Am J Kidney Dis. 1985;6(3):143-148.
28. Kriz W, Le Hir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005;67(2):404-419.
29. Glazebrook KN, McGrath FP, Steele BT. Prenatal compensatory renal growth: documentation with US. Radiology. 1993;189(3):733-735.
30. Douglas-Denton R, Moritz KM, Bertram JF, Wintour EM. Compensatory renal growth after unilateral nephrectomy in the ovine fetus. J Am Soc Nephrol. 2002;13(2):406-410.
31. Vu KH, Van Dyck M, Daniels H, Proesmans W. Renal outcome of children with one functioning kidney from birth. A study of 99 patients and a review of the literature. Eur J Pediatr. 2008;167(8):885-890.
32. Woolf AS, Hillman KA. Unilateral renal agenesis and the congenital solitary functioning kidney: developmental, genetic and clinical perspectives. BJU Int. 2007;99(1):17-21.
33. Saxena AB, Myers BD, Derby G, et al. Adaptive hyperfiltration in the aging kidney after contralateral nephrectomy. Am J Physiol Renal Physiol. 2006;291(3):F629-F634.
34. Galindo Sacristán P, Osuna Ortega A, Martínez Sánchez T, Palomares Bayo M, Osorio Moratalla JM, Asensio Peinado C. Assessment of long-term renal function after nephrectomy. Study of 53 patients [in Spanish]. Med Clin (Barc). 2005;125(3):81-83.
35. Ohishi A, Suzuki H, Nakamoto H, et al. Status of patients who underwent uninephrectomy in adulthood more than 20 years ago. Am J Kidney Dis. 1995;26(6):889-897.
36. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl JMed. 2003;348(2):101-108.
37. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 2006;70(1):104-110.
38. Schreuder MF, Langemeijer ME, Bökenkamp A, Delemarre-Van de Waal HA, Van Wijk JA. Hypertension and microalbuminuria in children with congenital solitary kidneys. J Paediatr Child Health. 2008;44(6):363-368.
39. Dursun H, Bayazit AK, Cengiz N, et al. Ambulatory blood pressure monitoring and renal functions in children with a solitary kidney. Pediatr Nephrol. 2007;22(4):559-564.
40. Heinonen PK. Gestational hypertension and preeclampsia associated with unilateral renal agenesis in women with uterine malformations. Eur J Obstet Gynecol Reprod Biol. 2004;114(1):39-43.
41. Levitt GA, Yeomans E, Dicks Mireaux C, Breatnach F, Kingston J, Pritchard J. Renal size and function after cure of Wilms' tumour. Br J Cancer. 1992;66(5):877-882.
42. Hakim RM, Goldszer RC, Brenner BM. Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int. 1984;25(6):930-936.
43. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145(3):185-196.
44. Zoja C, Benigni A, Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens. 2004;13(1):31-37.
45. Lea J, Greene T, Hebert L, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med. 2005;165(8):947-953.
46. Praga M, Hernández E, Herrero JC, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111-2118.
47. Baudoin P, Provoost AP, Molenaar JC. Renal function up to 50 years after unilateral nephrectomy in childhood. Am J Kidney Dis. 1993;21(6):603-611.
48. Ritchey ML. Prognosis of the solitary kidney. In: Kramer SA, ed. Problems in Urology. Philadelphia, Lippincott Williams and Wilkins; 1990:595-605.
49. Stuveling EM, Bakker SJ, Hillege HL, de Jong PE, Gans RO, de Zeeuw D. Biochemical riskmarkers: a novel area for better prediction of renal risk? Nephrol Dial Transplant. 2005;20(3):497-508.
50. Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. Am Soc Nephrol. 2004;15(12):3184-3191.
51. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53(4):596-605.
52. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007;22(4):1087-1092.
53. Fox ER, Benjamin EJ, Sarpong DF, et al. The relation of C-reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol. 2010;11:1.
54. Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68(2):766-772.
55. González E, Gutiérrez E, Morales E, et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 2005;68(1):263-270.
56. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):293-301.
57. Lee PH, Chang HY, Tung CW, et al. Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults. Am J Med Sci. 2009;338(3):185-189.
58. Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K. Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol. 2009;24(4):753-759.